Actuate Therapeutics ACTU
NASDAQ ACTU
$0.62 +0.02 (+2.85%)
At close: Oct 20, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Non-Current Assets (2024 - 2026)

Updated

Actuate Therapeutics (ACTU) posted Non-Current Assets of $451,398 for Q2 2026, up 61.0% from $280,342 a year earlier.

Analysis

Actuate Therapeutics (ACTU) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Actuate Therapeutics' Non-Current Assets came in at $392,491, up 255.0% from FY2024.

  • In prior years, Actuate Therapeutics' Non-Current Assets was $110,548 in FY2024.
  • The Q2 2026 figure stands as the highest quarterly Non-Current Assets since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 141.29 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 101.45 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 87.87 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 35.42 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 159.77 Bn
10 Actuate Therapeutics 14.74 Mn -26.26 Mn - 451,398.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 451,398.00
Dec 31, 2025 392,491.00
Sep 30, 2025 269,934.00
Jun 30, 2025 280,342.00
Mar 31, 2025 234,475.00
Dec 31, 2024 110,548.00
Jun 30, 2024 1.18 Mn
API Access

Actuate Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ACTU&period=max&api_key=YOUR_API_KEY